Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
- 1 September 1990
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 76 (1), 101-107
- https://doi.org/10.1111/j.1365-2141.1990.tb07843.x
Abstract
Summary. We have investigated the effects of purified IgG fractions from plasma containing the lupus anticoagulant (LAC) and/or IgG anticardiolipin antibody (ACA) on the degradation of factor Va by an activated protein C-protein S complex. Plasma samples from 10 patients were studied. LAC was detected by a Russell's Viper venom technique. ACA was determined by ELISA. IgG fractions were obtained from each plasma sample by protein A-Sepharose fractionation. This fraction was shown to exhibit ACAILAC activity. Using purified activated protein C (APC), protein S and phosphati-dylserine/phosphatidylcholine, factor Va degradation was assessed in the presence and absence of IgG fractions from LAC/ACA containing plasmas. After 2 min incubation the mean factor Va degradation by APC and protein S in the presence of IgG LAC/ACA fractions was 14% compared with 52% with normal IgG. A similar effect was seen when phospholipid was substituted by washed freeze-thawed platelets. Experiments employing varying concentrations of protein S and phospholipid revealed marked differences in respect of the inhibitory specificity of the different antiphospholipid antibodies. These results indicate that antiphospholipid antibodies have an inhibitory effect on the activated protein C/protein S complex and provide some explanation for a relationship between antiphospholipid antibodies and thrombosis.Keywords
This publication has 20 references indexed in Scilit:
- The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complexBiochemical Journal, 1986
- Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 casesAmerican Journal of Hematology, 1985
- Protein S and the Regulation of Activated Protein CSeminars in Thrombosis and Hemostasis, 1984
- Lupus anticoagulant in pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Structure and Function of Protein CSeminars in Thrombosis and Hemostasis, 1984
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying compositionBiochemistry, 1982
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- POSSIBLE RELATIONSHIP BETWEEN LUPUS INHIBITOR AND RECURRENT ABORTION IN YOUNG WOMENThe Lancet, 1980
- INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)Acta Medica Scandinavica, 1975